Newsfeeds - Spark Newswire

2 minute read

Why NeuroBo Pharmaceuticals Is Trading Higher By Around 55%; Here Are 25 Stocks Moving Premarket

Today, 5:07 AM

Gainers NeuroBo Pharmaceuticals, Inc. (NASDAQ: NRBO) rose 54.6% to $26.07 in pre-market trading after the company entered into an exclusive license agreement with Dong-A.

ADTX

2 minute read

Movers

12 Health Care Stocks Moving In Wednesday’s After-Market Session

By Benzinga Insights

Today, 5:07 AM

Gainers Enochian BioSciences (NASDAQ:ENOB) shares moved upwards by 27.8% to $2.3 during Wednesday's after-market session. The market value of their outstanding shares is at $121.7 million.

ATXI

6 minute read

Why Comera Life Sciences Shares Jumped 101%; Here Are 74 Biggest Movers From Yesterday

By Lisa Levin

Today, 5:07 AM

Gainers Akero Therapeutics, Inc. (NASDAQ: AKRO) shares jumped 136.8% to settle at $29.05 on Tuesday after the company's Phase 2b HARMONY study met its primary endpoint for both the 50mg and 28mg EFX dose groups.

AAPL

6 minute read

Why ShiftPixy Surged Around 177%; Here Are 71 Biggest Movers From Yesterday

By Lisa Levin

Today, 5:07 AM

Gainers ShiftPixy, Inc. (NASDAQ: PIXY) shares surged 176.5% to close at $31.00 on Thursday after the company announced plans to spin-off ShiftPixy Labs and dividend its digital securities to shareholders.

AEO

10 minute read

Options

Stocks That Hit 52-Week Lows On Thursday

By Benzinga Insights

Today, 5:07 AM

On Thursday, 168 companies reached new 52-week lows.

ACCO

2 minute read

News

Ensysce Biosciences And Quotient Sciences Announce A Partnership On The Development And Clinical Testing Of Ensysce’s PF614-MPAR, A Novel Opioid Designed To Prevent Abuse And Overdose

By Benzinga Newsdesk

Today, 5:07 AM

Partnership further expedites Ensysce’s development pipeline NOTTINGHAM, UK; August 31, 2022 – Ensysce Biosciences, Inc. ("Ensysce" or the "Company") (NASDAQ:ENSC)(OTC:ENSCW), a

ENSC

1 minute read

Ensysce Biosciences Announces Completion Of Clinical Portion Of Human Abuse Potential Trial PF614-103

By Benzinga Newsdesk

Today, 5:07 AM

Completion of Clinical Portion Represents Critical Milestone Towards Commercialization Nasal Opioid Abuse Being Explored for PF614 Data From Trial Expected in September 2022

ENSC

5 minute read

This Biotechnology Stock Tumbled 37%; Here Are 70 Biggest Movers From Yesterday

By Lisa Levin

Today, 5:07 AM

Gainers Bright Minds Biosciences Inc. (NASDAQ: DRUG) shares climbed 135.9% to close at $2.17 on Thursday.

ALLR

8 minute read

Why FlexShopper Surged Over 47%; Here Are 104 Biggest Movers From Yesterday

By Lisa Levin

Today, 5:07 AM

Gainers Digital Media Solutions, Inc. (NYSE: DMS) jumped 78.8% to close at $2.11. Digital Media Solutions recently reported worse-than-expected Q2 EPS and sales results.

ABSI

5 minute read

Why Matterport Is Trading Higher By Around 25%, Here Are 73 Stocks Moving In Thursday’s Mid-Day Session

By Lisa Levin

Today, 5:07 AM

Gainers Timber Pharmaceuticals, Inc. (NYSE: TMBR) shares rose 63.8% to $0.1769. Timber Pharmaceuticals recently announced closing of $8.0 million public offering.

ABSI